Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences

被引:4
作者
Liu, Shaonan [1 ]
Lai, Jiaqi [1 ]
Wu, Lei [2 ]
Guo, Xinfeng [1 ]
机构
[1] Guangzhou Univ Chinese Med, Evidence Based Med & Clin Res Serv Grp, Affiliated Hosp 2, Guangdong Prov Hosp Chinese Med, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China
[2] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Resp Dept, Guangzhou, Guangdong, Peoples R China
来源
PATIENT PREFERENCE AND ADHERENCE | 2021年 / 15卷
基金
国家重点研发计划;
关键词
patient preference; Chinese medicine; COPD; COPD; EXACERBATIONS; PERCEPTION; MEDICATION; CARE; NONADHERENCE; ADHERENCE; PHYSICIAN; SYMPTOMS; GRANULES;
D O I
10.2147/PPA.S316872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The patient's preference plays an important role in clinical practice. There currently is no available evidence regarding the perception and attitudes of patients with chronic obstructive pulmonary disease (COPD) towards the use of Chinese medicine (CM) approaches. This study was designed to explore preferences and factors associated with CM among COPD patients. Patients and Methods: A pilot survey was conducted among COPD patients using a structured, pre-tested questionnaire. The perceptions of CM therapies (including herbal medicine, non-pharmacotherapies), and expected clinical outcomes were investigated based on patient preference. Factors associated with preference of treatment scenarios were estimated in order of importance. Results: Thirty patients were enrolled in the survey, including 27 males and 3 females. Two-thirds of the patients preferred integrative Chinese and Western medicine for the treatment of COPD. Chinese patent medicines and CM decoction therapy were more popular than CM injections. The preferred non-drug therapy was point application, followed by acupuncture, Tai chi, or Qigong. More than 70% of patients reported that important clinical outcomes were improvements in lung function (77%) and dyspnea, cough, and sputum symptoms (73%), followed by exercise endurance (50%). Besides clinical efficacy, costs and side effects were also important factors for treatment selection. Conclusion: This pilot study showed that Chinese patent medicine and CM decoctions were preferred options for complementary medicines to combine with routine pharmacotherapy for COPD treatment according to the patients' preferences. The improvement of dyspnea, cough symptoms, and lung function was the most desired clinical outcomes for patients. Quicker symptom relief, lower costs, and fewer side effects were key attributes for the treatment selection. Further research with a larger sample size is needed to definitively address the comprehensive conclusion.
引用
收藏
页码:1529 / 1535
页数:7
相关论文
共 38 条
  • [1] Patients' preferences within randomised trials: systematic review and patient level meta-analysis
    Adamson, Simon J.
    Bland, J. Martin
    Hay, Elaine M.
    Johnson, Ruth E.
    Jones, Gareth T.
    Kitchener, Henry
    Moffett, Jennifer A. Klaber
    Macfarlane, Gary J.
    MacPherson, Hugh
    McLean, Sionnadh
    Nelson, Linsey
    Salisbury, Chris
    Thomas, Elaine
    Tilbrook, Helen E.
    Torgerson, David J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 337 : 85 - 87
  • [2] [Anonymous], 2020, Global Strategy for the Diagnosis, Management and Prevention of COPD
  • [3] Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next?
    Bender, Bruce G.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2014, 20 (02) : 132 - 137
  • [4] Preferences for cancer treatments: an overview of methods and applications in oncology
    Blinman, P.
    King, M.
    Norman, R.
    Viney, R.
    Stockler, M. R.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (05) : 1104 - 1110
  • [5] Patient adherence in COPD
    Bourbeau, J.
    Bartlett, S. J.
    [J]. THORAX, 2008, 63 (09) : 831 - 838
  • [6] Perception of symptoms and quality of life - comparison of patients' and physicians' views in the COPD MIRROR study
    Celli, Bartolome
    Blasi, Francesco
    Gaga, Mina
    Singh, Dave
    Vogelmeier, Claus
    Pegoraro, Valeria
    Caputo, Nicoletta
    Agusti, Alvar
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2189 - 2196
  • [7] Oral Chinese Herbal Medicine Combined with Pharmacotherapy for Stable COPD: A Systematic Review of Effect on BODE Index and Six Minute Walk Test
    Chen, Xiankun
    May, Brian
    Di, Yuan Ming
    Zhang, Anthony Lin
    Lu, Chuanjian
    Xue, Charlie Changli
    Lin, Lin
    [J]. PLOS ONE, 2014, 9 (03):
  • [8] A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease
    Chen, Yuanbin
    Shergis, Johannah Linda
    Wu, Lei
    Yu, Xuhua
    Zeng, Qigang
    Xu, Yinji
    Guo, Xinfeng
    Zhang, Anthony Lin
    Xue, Charlie Changli
    Lin, Lin
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2016, 29 : 94 - 108
  • [9] Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France
    Chouaid, Christos
    Germain, Nicola
    De Pouvourville, Gerard
    Aballea, Samuel
    Korchagina, Daria
    Baldwin, Michael
    Le Lay, Kate
    Luciani, Laura
    Toumi, Mondher
    Devillier, Philippe
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 785 - 792
  • [10] Coyle M, 2014, ALTERN THER HEALTH M, V20, P10